IPEC likes what China's doing with excipients; Ranbaxy reports surprise loss;

> A 140% surge in North American sales, driven by its generic Lipitor, was not enough to keep Ranbaxy Laboratories from reporting a quarterly loss. Story

> Uganda has banned 67 drugs from Indian maker Flamingo, claiming that they are substandard. Story

> CVS Caremark ($CVS) realized an 18.4% earnings jump in the last quarter, having grabbed business during the Walgreen ($WAG), Express Scripts ($ESRX) fight. Story

> New guidelines from China's State Food and Drug Administration (SFDA) for excipients has impressed The International Pharmaceutical Excipients Council (IPEC) Americas, which says they are consistent with its own guidelines. Story

And Finally... University of Central Florida scientists think they have stumbled upon a simpler and more efficient way to mass produce the structured nanoparticles used for drug delivery and production. Story

Suggested Articles

Pfizer says two lots of migraine med Relpax failed to meet microbial standards and may be contaminated with genera pseudomonas and burkholderia.

Emcure has had its share of run-ins with the FDA in the past over the sterility of its plants. Now, it can notch one more black mark on its belt.

The FDA has slapped a warning letter on an Indian solvent recycler that may have contributed to the contamination of blood pressure meds.